GLP1R and obesity due to melanocortin 4 receptor deficiency: Semaglutide offered the most pronounced chemoprotective effects, with the effects of all GLP‐1 RAs generally greater in younger adult patients of white ethnicity, living with obesity, and in those with longer duration T2D.